Does MOMELOTINIB Cause Anaemia? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Anaemia have been filed in association with MOMELOTINIB (Ojjaara). This represents 6.5% of all adverse event reports for MOMELOTINIB.
59
Reports of Anaemia with MOMELOTINIB
6.5%
of all MOMELOTINIB reports
5
Deaths
10
Hospitalizations
How Dangerous Is Anaemia From MOMELOTINIB?
Of the 59 reports, 5 (8.5%) resulted in death, 10 (16.9%) required hospitalization.
Is Anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOMELOTINIB. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does MOMELOTINIB Cause?
Thrombocytopenia (89)
Death (77)
Drug ineffective (75)
Diarrhoea (51)
Myelofibrosis (51)
Condition aggravated (49)
Dizziness (41)
Pneumonia (41)
Fatigue (39)
Platelet count decreased (38)
What Other Drugs Cause Anaemia?
LENALIDOMIDE (5,322)
CARBOPLATIN (5,312)
RIBAVIRIN (5,130)
ASPIRIN (4,568)
CYCLOPHOSPHAMIDE (4,486)
RITUXIMAB (4,399)
DEXAMETHASONE (4,352)
ADALIMUMAB (3,994)
PACLITAXEL (3,949)
METHOTREXATE (3,913)
Which MOMELOTINIB Alternatives Have Lower Anaemia Risk?
MOMELOTINIB vs MOMETASONE
MOMELOTINIB vs MOMETASONE FUROATE
MOMELOTINIB vs MOMETASONE FUROATE\OLOPATADINE
MOMELOTINIB vs MONOMETHYL
MOMELOTINIB vs MONTELUKAST